Zalcitabine approved under accelerated drug review policy.
D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D013997:Time Factors; D016047:Zalcitabine / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D015507:Drugs, Investigational; D015215:Zidovudine; D016047:Zalcitabine